EvlaBio logo

EvlaBio

Website
Current Valuation
N/A
As of July 7, 2025
Total Funding Raised
$24.6M
Last Round
Seed Round

$24.4M

Last Funding
Jul 2025

Funding date

Capital Efficiency
N/A

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

EvlaBio is currently valued at N/A as of July 7, 2025. The company has raised a total of $24.6M in funding.

Investment Perspective

EvlaBio's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track EvlaBio Valuation Updates

Get notified when EvlaBio raises new funding or valuation changes

Explore More Data
Detailed analysis for EvlaBio

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

What is EvlaBio Worth in 2025?

As of 2025, EvlaBio is valued at N/A, based on the company's Seed Round funding round in July 7, 2025. This valuation positions EvlaBio as one of the leading private companies in the sector.

EvlaBio Valuation History

EvlaBio's funding history demonstrates steady growth and investor confidence.

How EvlaBio Valuation is Determined

Private company valuations like EvlaBio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

EvlaBio Valuation FAQs

Is EvlaBio profitable?

EvlaBio has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does EvlaBio's valuation compare to competitors?

EvlaBio is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will EvlaBio IPO?

EvlaBio has not announced plans for an initial public offering. Until an IPO, investors can access EvlaBio shares through secondary market platforms.